6 Multibagger Stocks to Buy Before They Explode in 2026

A promotional video outlines six growth-stock ideas and markets The Motley Fool’s Stock Advisor service, using stock prices from Dec. 26, 2025 and publishing the video on Dec. 27, 2025. The piece highlights Stock Advisor’s claimed historical average return of 991% versus a 196% return for the S&P 500 and cites examples (Netflix, Nvidia); disclosures state Neil Rozenbaum holds positions in DLocal, Oscar Health and Shift4 Payments, and The Motley Fool holds/recommends Lemonade, Sezzle, Shift4 Payments and TransMedics, including a recommended options spread on DLocal (long Jan 2027 $7 calls / short Jan 2027 $10 calls).

Analysis

Market structure: The short video-driven rotation favors growth/AI leaders (NVDA, NFLX) and fintech/payment processors (DLO, FOUR, SEZL) while pressuring high-volatility/insurance names (LMND). NVDA benefits from concentrated GPU demand — expect pricing power to persist through 2026 if data-center utilization >70% and lead times remain >12 weeks; payment processors win if transaction volumes grow >5% YoY. Risk-on flows lift equities and EM FX, push 10y yields +10–25bp on growth optimism, and raise single-name options IV for retail-favored tickers.

Risk assessment: Tail risks include regulatory crackdowns on cross-border fintech (DLO/SEZL) or insurance tech (LMND) within 6–18 months, a demand shock to AI hardware that could trim NVDA revenue 20–40% in a severe scenario, and supply-chain shocks for semiconductors. Immediate (days) risk: retail momentum and option pinning; short-term (weeks) risk: earnings/guidance shocks; long-term (quarters) risk: structural margin normalization and regulatory action. Hidden dependencies: platform concentration on NVIDIA GPUs and advertising/ARPU sensitivity for NFLX.

Trade implications: Tactical longs in NVDA (core overweight 1–3% portfolio) and selective payment processors (FOUR, DLO 0.5–1.5% each) are highest conviction through 12–18 months; use LEAP calls (12–18m, ~Δ0.30) to target asymmetric upside and limit capital. Initiate small, hedged short/put exposure to LMND (0.5–1% via puts, strike ~15–25% OTM, 3–6m) to monetize downside skew and sell covered calls post-earnings on NFLX if rally >10%. Pair trade idea: long TMDX (1%) vs short OSCR (1%) to capture device M&A/operational optionality versus insurer execution risk.

Contrarian angles: Consensus may underprice regulatory drift and concentration risk (NVDA platform dependence) — a normalization could trigger a 20–40% pullback, creating buying windows. Conversely, healthcare names like TMDX and selected payments (FOUR) are underfollowed; if Q1–Q2 2026 catalyst cadence is positive, expect 30–80% re-rating. Watch retail options positioning and open interest in LMND/NVDA for early signs of violent moves or forced deleveraging.

Key Decisions for Investors

• Establish a 1.5–3% long position in NVDA using Jan 2027 LEAP calls (target Δ≈0.30) or equivalent equity, hold 12–18 months, take profits at +40–100% or cut losses at -25%; increase if data-center utilization reports >70% and guidance raised.
• Add 0.5–1.5% long positions in payment processors DLO and FOUR (split exposure), implemented via 3–6 month call spreads ahead of next quarterly results; target +30–50% exits, stop-loss -20%.
• Initiate a defensive short/put on LMND sized 0.5–1% via 3–6 month puts ~20% OTM (roll if IV collapses), profit-take on a 30% move lower or cut at a 25% adverse move; regulatory filings in next 60–120 days are key triggers.
• Execute a pair trade: go long TMDX 1% and short OSCR 1% to express device/M&A optionality vs insurer execution risk; reassess after two quarterly reports or if spread moves >30%.
• If NFLX rallies >10% post-earnings, sell 2–4 week covered calls to harvest elevated premium; otherwise buy 3–6 month call spreads on dips >10% from today’s levels to play subscriber rebound with limited downside.